Chicago Unites in Research to End HIV (CURE HIV)

Funded by Gilead Sciences, Inc., Chicago Unites in Research to End HIV (CURE HIV) is a community-academic partnership among three organizations at the forefront of HIV care, prevention, and research across Chicago – AIDS Foundation of Chicago, Ann & Robert H. Lurie Children’s Hospital, and the  Evaluation, Data Integration, and Technical Assistance Program (EDIT). This project will establish foundational knowledge for the development and advancement of a cure research agenda.

The CURE HIV project seeks to address three research questions with key community stakeholders, including individuals directly impacted by HIV, as follows:

  1. What ethical considerations, including risks and benefits, need to be taken into account in cure research?
  2. How acceptable is cure research to impacted communities?
  3. What are the best ways to engage individuals and communities in cure research?

In addition, the CURE HIV Project seeks to increase communication, transparency, and collaboration between community members and scientists. The long-term goal is to increase acceptability and willingness to engage in future cure research and therapy among young men who have sex with men (MSM), MSM of color, transgender women, and cisgender women of color, while simultaneously increasing scientists’ ability to engage in ethical and acceptable cure research.

Co-Principal Investigators: Drs. George Greene and Amy Johnson
Team Member: Jim Pickett
Funder: Gilead Sciences, Inc.